Geode Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Buy
630,148
+314,407
+100% +$1.23M ﹤0.01% 3074
2025
Q1
$1.2M Buy
315,741
+9,990
+3% +$37.9K ﹤0.01% 3243
2024
Q4
$1.66M Sell
305,751
-1,207
-0.4% -$6.56K ﹤0.01% 3198
2024
Q3
$1.29M Buy
306,958
+70,070
+30% +$294K ﹤0.01% 3266
2024
Q2
$699K Sell
236,888
-2,347
-1% -$6.93K ﹤0.01% 3447
2024
Q1
$663K Buy
239,235
+20,457
+9% +$56.7K ﹤0.01% 3515
2023
Q4
$621K Hold
218,778
﹤0.01% 3533
2023
Q3
$565K Buy
218,778
+33,908
+18% +$87.5K ﹤0.01% 3555
2023
Q2
$799K Hold
184,870
﹤0.01% 3441
2023
Q1
$283K Hold
184,870
﹤0.01% 3887
2022
Q4
$292K Sell
184,870
-349
-0.2% -$551 ﹤0.01% 3901
2022
Q3
$229K Buy
185,219
+8,197
+5% +$10.1K ﹤0.01% 4125
2022
Q2
$357K Buy
177,022
+2,164
+1% +$4.36K ﹤0.01% 3943
2022
Q1
$437K Buy
174,858
+7,095
+4% +$17.7K ﹤0.01% 4003
2021
Q4
$625K Hold
167,763
﹤0.01% 3931
2021
Q3
$672K Buy
167,763
+34,194
+26% +$137K ﹤0.01% 3886
2021
Q2
$594K Buy
133,569
+5,101
+4% +$22.7K ﹤0.01% 3859
2021
Q1
$1.18M Buy
128,468
+24,769
+24% +$227K ﹤0.01% 3482
2020
Q4
$1.05M Buy
103,699
+41,037
+65% +$416K ﹤0.01% 3355
2020
Q3
$265K Buy
62,662
+6,250
+11% +$26.4K ﹤0.01% 3629
2020
Q2
$390K Sell
56,412
-1,112
-2% -$7.69K ﹤0.01% 3457
2020
Q1
$161K Buy
57,524
+39,967
+228% +$112K ﹤0.01% 3618
2019
Q4
$85K Buy
17,557
+2,158
+14% +$10.4K ﹤0.01% 3999
2019
Q3
$31K Buy
+15,399
New +$31K ﹤0.01% 4109